Works matching IS 08876924 AND DT 2015 AND VI 29 AND IP 5


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.

    Published in:
    Leukemia (08876924), 2015, v. 29, n. 5, p. 1041, doi. 10.1038/leu.2014.332
    By:
    • Cornelissen, J J;
    • Versluis, J;
    • Passweg, J R;
    • van Putten, W L J;
    • Manz, M G;
    • Maertens, J;
    • Beverloo, H B;
    • Valk, P J M;
    • van Marwijk Kooy, M;
    • Wijermans, P W;
    • Schaafsma, M R;
    • Biemond, B J;
    • Vekemans, M-C;
    • Breems, D A;
    • Verdonck, L F;
    • Fey, M F;
    • Jongen-Lavrencic, M;
    • Janssen, J J W M;
    • Huls, G;
    • Kuball, J
    Publication type:
    Article
    12

    Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.

    Published in:
    Leukemia (08876924), 2015, v. 29, n. 5, p. 1092, doi. 10.1038/leu.2014.331
    By:
    • Dolatshad, H;
    • Pellagatti, A;
    • Fernandez-Mercado, M;
    • Yip, B H;
    • Malcovati, L;
    • Attwood, M;
    • Przychodzen, B;
    • Sahgal, N;
    • Kanapin, A A;
    • Lockstone, H;
    • Scifo, L;
    • Vandenberghe, P;
    • Papaemmanuil, E;
    • Smith, C W J;
    • Campbell, P J;
    • Ogawa, S;
    • Maciejewski, J P;
    • Cazzola, M;
    • Savage, K I;
    • Boultwood, J
    Publication type:
    Article
    13

    The impact of SF3B1 mutations in CLL on the DNA-damage response.

    Published in:
    Leukemia (08876924), 2015, v. 29, n. 5, p. 1133, doi. 10.1038/leu.2014.318
    By:
    • te Raa, G D;
    • Derks, I A M;
    • Navrkalova, V;
    • Skowronska, A;
    • Moerland, P D;
    • van Laar, J;
    • Oldreive, C;
    • Monsuur, H;
    • Trbusek, M;
    • Malcikova, J;
    • Lodén, M;
    • Geisler, C H;
    • Hüllein, J;
    • Jethwa, A;
    • Zenz, T;
    • Pospisilova, S;
    • Stankovic, T;
    • van Oers, M H J;
    • Kater, A P;
    • Eldering, E
    Publication type:
    Article
    14
    15
    16

    Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.

    Published in:
    Leukemia (08876924), 2015, v. 29, n. 5, p. 1143, doi. 10.1038/leu.2014.314
    By:
    • Crucitti, L;
    • Crocchiolo, R;
    • Toffalori, C;
    • Mazzi, B;
    • Greco, R;
    • Signori, A;
    • Sizzano, F;
    • Chiesa, L;
    • Zino, E;
    • Lupo Stanghellini, M T;
    • Assanelli, A;
    • Carrabba, M G;
    • Marktel, S;
    • Marcatti, M;
    • Bordignon, C;
    • Corti, C;
    • Bernardi, M;
    • Peccatori, J;
    • Bonini, C;
    • Fleischhauer, K
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.

    Published in:
    Leukemia (08876924), 2015, v. 29, n. 5, p. 1060, doi. 10.1038/leu.2014.335
    By:
    • Schetelig, J;
    • Schaich, M;
    • Schäfer-Eckart, K;
    • Hänel, M;
    • Aulitzky, W E;
    • Einsele, H;
    • Schmitz, N;
    • Rösler, W;
    • Stelljes, M;
    • Baldus, C D;
    • Ho, A D;
    • Neubauer, A;
    • Serve, H;
    • Mayer, J;
    • Berdel, W E;
    • Mohr, B;
    • Oelschlägel, U;
    • Parmentier, S;
    • Röllig, C;
    • Kramer, M
    Publication type:
    Article
    29